SCHEMBL8155649

SCHEMBL8155649

C/C(=N\c1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.58
NOS1 P29475 2/20 0.58
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 2/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HTR3E A5X5Y0 1/20 0.48
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
SLC22A3 O75751 1/20 0.48
HTR3B O95264 1/20 0.48
PLAU P00749 1/20 0.48
HTR3A P46098 1/20 0.48
HTR3D Q70Z44 1/20 0.48
HTR3C Q8WXA8 1/20 0.48
MAPT P10636 4/20 0.47
CYP2D6 P10635 2/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1890790 1.00 NOS3 (0.58) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL1890792 1.00 NOS3 (0.58) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL15073401 0.95 NOS3 (0.52) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL15073411 0.89 NOS1 (0.56) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL16382908 0.87 CYP2D6 (0.53) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL11421052 0.87 CYP2D6 (0.53) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL11421050 0.87 CYP2D6 (0.53) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL9302496 0.87 ESR1 (0.53) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL22594341 0.87 CYP2D6 (0.63) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL15073407 0.85 LMNA (0.49) NOS3NOS1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0239391-B1 1,2,6-triphenyl-4(1H)-pyridinone and pyridinethione derivatives, production and uses thereof KUMIAI CHEMICAL INDUSTRY CO (JP) 1994-03-02 EP claimed
EP-0239391-A2 1,2,6-triphenyl-4(1H)-pyridinone and pyridinethione derivatives, production and uses thereof KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1987-09-30 EP claimed
US-11673125-B2 Metal oxide-supported earth-abundant metal catalysts for highly efficient organic transformations THE UNIVERSITY OF CHICAGO (US) 2023-06-13 US disclosed
US-11673125-B2 Metal oxide-supported earth-abundant metal catalysts for highly efficient organic transformations THE UNIVERSITY OF CHICAGO (US) 2023-06-13 US disclosed
US-20220013729-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-01-13 US disclosed
EP-3227018-B1 CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS UNIV VIRGINIA COMMONWEALTH (US) 2021-06-30 EP disclosed
US-10953393-B2 Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations THE UNIVERSITY OF CHICAGO (US) 2021-03-23 US disclosed
US-10953393-B2 Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations THE UNIVERSITY OF CHICAGO (US) 2021-03-23 US disclosed
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same LG CHEM, LTD. 2021-02-02 US disclosed
US-20200324276-A1 METAL OXIDE-SUPPORTED EARTH-ABUNDANT METAL CATALYSTS FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS THE UNIVERSITY OF CHICAGO 2020-10-15 US disclosed
EP-2892879-B1 CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES GOUSSEV DMITRI (CA) 2020-07-22 EP disclosed
US-20070073065-A1 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-03-29 US disclosed
US-7193092-B2 Chiral diphosphorus compounds and their transition metal complexes LANXESS DEUTSCHLAND GMBH (DE) 2007-03-20 US disclosed
US-7193092-B2 Chiral diphosphorus compounds and their transition metal complexes LANXESS DEUTSCHLAND GMBH (DE) 2007-03-20 US disclosed
EP-1286937-B1 CHIRAL MONOPHOSPHITES AS LIGANDS FOR ASYMETRICAL HDROGENATION STUDIENGESELLSCHAFT KOHLE MBH (DE) 2007-03-14 EP disclosed
US-6072085-A COMBINING SUBSTRATE IMINE, NUCLEOPHILIC ACTIVATOR, SILANE, METAL CATALYST, WHEREIN CATALYST CATALYZES REDUCTION OF IMINE BY HYDROSILATION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2000-06-06 US disclosed
EP-0239391-B1 1,2,6-triphenyl-4(1H)-pyridinone and pyridinethione derivatives, production and uses thereof KUMIAI CHEMICAL INDUSTRY CO (JP) 1994-03-02 EP disclosed
US-4871751-A 1,2,6-Triphenyl-4(1H)-pyridinone derivatives, and their use as fungicides KUMAI CHEMICAL INDUSTRY CO., LTD. (JP) 1989-10-03 US disclosed
US-4757081-A Agriculture, horticulture KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1988-07-12 US disclosed
EP-0239391-A2 1,2,6-triphenyl-4(1H)-pyridinone and pyridinethione derivatives, production and uses thereof KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1987-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same NR2E3, ALDH1A2, CRY1 NOS3 2913/4885NOS1 2518/4885MEN1 1825/4885
US-10953393-B2 Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations SBK1, SIK1, SIK2 NOS3 619/4885NOS1 566/4885MEN1 1548/4885
US-20070073065-A1 Substituted optically active disphosphine compound DHPS, DOHH, DHODH NOS3 3260/4885NOS1 1968/4885MEN1 792/4885
US-20220013729-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CYP1B1, CYP1A1 NOS3 1089/4885NOS1 186/4885MEN1 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.